| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.003 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.00047 | 1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.00029 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.00051 | 1 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00023 | 1 |